Time Pharmaceuticals to Issue IPO via Book Building Method

Time Pharmaceuticals Ltd. has received regulatory approvals to issue its Initial Public Offering (IPO) via the Book Building method. The company has appointed Nabil Investment Banking Ltd. as the issue manager. Operating for over 30 years, the WHO-GMP-certified company is based in Gaindakot, Nawalpur, with marketing offices in Lalitpur and over 300 employees.

It manufactures 200+ quality medicines under brands like Sinex, Paraflam, and Pulmarin, contributing to Nepal’s self-sufficiency in healthcare. The company has expanded its trade network through partnerships with Square Pharmaceuticals (Bangladesh) and HK-VJM Limited (Hong Kong) for exports. The IPO issuance agreement was signed on Falgun 15, 2081 (Feb 27, 2025) by Managing Director Surdshan Lal Shrestha and CEO Manish Narayan Joshi of Nabil Investment Banking.